MyFinsight

HomeAboutContact
Curious boy with magnifying glass
A worm made of letters APL
A worm made of letters BOA

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2024 MyFinsight. All rights reserved.

Context Therapeutics Inc. (CNTX)

For the quarter ending 2025-06-30, CNTX made $930,852 in revenue. -$8,827,510 in net income. Net profit margin of -948.33%.

Overview

Revenue
$930,852
Net Income
-$8,827,510
Net Profit Margin
-948.33%
Unit: Dollar
Revenue Breakdown
    • Interest income
    • Other income (expense)

Unit: Dollar
2025-06-30
Other income (expense)27,080
Other segment items396,481
Professional fees543,168
Operating expenses-CTIM761,445,862
Operating expenses-CT951,488,530
Operating expenses-CT2023,149,238
Personnel-related costs2,345,969
Share-based compensation389,114
Loss from operations-9,758,362
Interest income903,772
Net loss-8,827,510
Unit: Dollar

Income Statement

DownloadDownload image
Net loss-$8,827,510 Interest income$903,772 Other income(expense)$27,080 Loss from operations-$9,758,362 Share-based compensation$389,114 Personnel-related costs$2,345,969 Operating expenses-CT202$3,149,238 Operating expenses-CT95$1,488,530 Operatingexpenses-CTIM76$1,445,862 Professional fees$543,168 Other segment items$396,481